Publication Type
October 21, 2004
Who’s Afraid of RFID?
Afraid that your new electronics equipment from Best Buy is spying on you? It’s that tiny chip on the merchandise, hardly big enough see, that transmits radio signals that is causing all the anxiety.
October 12, 2004
The Fertile New Tax Fields of the USA
Little noticed during the presidential campaign was a call by France and Brazil for a system of global taxation to fight poverty.
October 7, 2004
Does America Have a Prescription Drug Problem?: The Perils of Ignoring the Economics of Pharmaceuticals
Critics claim the pharmaceutical industry is unique and therefore requires distinctive forms of regulation, such as price controls. But absent in this view is a systematic appraisal of the economics of the industry. Were their approach adopted, the consequences would be less innovation, fewer life-saving drugs, and a less-healthy citizenry than what could be possible.
October 7, 2004
Should Government Displace Innovators
In a nearly unprecedented act of foolishness, the Philadelphia city government is planning to wire the entire city for wi-fi Internet connections.
October 5, 2004
Beware of Liberals Who Profess to Care about the Deficit
In the midst of a presidential campaign, the economy is usually front and center of the debate.
September 30, 2004
The Age of Innovation — Even in Compensation
Tech companies have been able to hire and keep the best employees because they typically have compensated them generously.
September 28, 2004
"And the Winner Is...the Taxman"
When TV personality Oprah Winfrey gave away 276 new Pontiacs to her audience, some cynics called it just a publicity stunt.
September 23, 2004
Giving R&D Credit Where Credit is Due
Research and development is the foundation of technological advance, the engine that helps deliver miracle drugs, timesaving devices and the cutting-edge technology that generates new jobs and economic progress.
September 22, 2004
The Impact of Drug Reimportation and Price Controls: The U.S. and Massachusetts
Consumer groups and the media are putting pressure on public officials to allow U.S. citizens to reimport drugs from foreign countries like Canada. This report concludes reimportation programs or price controls would have a dramatic negative impact on drug development in the United States and, because it is home to a significant research center, on the economy of Massachusetts.


